Spyridopoulos, I., Luedemann, C., Chen, D., Kearney, M., Chen, D., Murohara, T., Principe, N., Isner, J.M. and Losordo, D.W.
Notes: The Myristoylated Protein Kinase C Peptide Inhibitor and cAMP-Dependent Protein Kinase Peptide Inhibitor were used in cell and animal studies to help specifically identify Protein Kinase A and C activities. The researchers used a range of 0-12uM Myristoylated Protein Kinase C Peptide Inhibitor for the studies. Protein Kinase A and C activities were measured using the SignaTECT® cAMP-Dependent Protein Kinase (PKA) Assay and SignaTECT® Protein Kinase C (PKC) Assay Systems, respectively. Experiments were performed in human umbilical vein endothelial cells (HUVECs), bovine aortic endothelial cells, mouse corneas, and guinea pigs. (3130)